365 related articles for article (PubMed ID: 17295178)
21. Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis.
Mahdi ZM; Synal-Hermanns U; Yoker A; Locher KP; Stieger B
Mol Pharmacol; 2016 Jul; 90(1):23-34. PubMed ID: 27112167
[TBL] [Abstract][Full Text] [Related]
22. Lipid flopping in the liver.
Linton KJ
Biochem Soc Trans; 2015 Oct; 43(5):1003-10. PubMed ID: 26517915
[TBL] [Abstract][Full Text] [Related]
23. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.
Deleuze JF; Jacquemin E; Dubuisson C; Cresteil D; Dumont M; Erlinger S; Bernard O; Hadchouel M
Hepatology; 1996 Apr; 23(4):904-8. PubMed ID: 8666348
[TBL] [Abstract][Full Text] [Related]
24. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.
Geuken E; Visser DS; Leuvenink HG; de Jong KP; Peeters PM; Slooff MJ; Kuipers F; Porte RJ
Hepatology; 2005 Nov; 42(5):1166-74. PubMed ID: 16250035
[TBL] [Abstract][Full Text] [Related]
25. Intrahepatic cholestasis of pregnancy (ICP): case report and review of the literature.
Keitel V; Dröge C; Stepanow S; Fehm T; Mayatepek E; Köhrer K; Häussinger D
Z Gastroenterol; 2016 Dec; 54(12):1327-1333. PubMed ID: 27936482
[TBL] [Abstract][Full Text] [Related]
26. Liver diseases related to MDR3 (ABCB4) gene deficiency.
Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
[TBL] [Abstract][Full Text] [Related]
27. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
[TBL] [Abstract][Full Text] [Related]
28. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
[TBL] [Abstract][Full Text] [Related]
29. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
[TBL] [Abstract][Full Text] [Related]
30. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction.
Dumoulin FL; Reichel C; Sauerbruch T; Spengler U
J Hepatol; 1997 Apr; 26(4):852-6. PubMed ID: 9126799
[TBL] [Abstract][Full Text] [Related]
31. Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene.
Rosmorduc O; Poupon R
Orphanet J Rare Dis; 2007 Jun; 2():29. PubMed ID: 17562004
[TBL] [Abstract][Full Text] [Related]
32. Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4- deficient mice.
Lamireau T; Bouchard G; Yousef IM; Clouzeau-Girard H; Rosenbaum J; Desmoulière A; Tuchweber B
Pediatr Res; 2007 Feb; 61(2):185-90. PubMed ID: 17237720
[TBL] [Abstract][Full Text] [Related]
33. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
[TBL] [Abstract][Full Text] [Related]
34. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis.
Pauli-Magnus C; Kerb R; Fattinger K; Lang T; Anwald B; Kullak-Ublick GA; Beuers U; Meier PJ
Hepatology; 2004 Mar; 39(3):779-91. PubMed ID: 14999697
[TBL] [Abstract][Full Text] [Related]
35. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
[TBL] [Abstract][Full Text] [Related]
36. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene.
Wasmuth HE; Glantz A; Keppeler H; Simon E; Bartz C; Rath W; Mattsson LA; Marschall HU; Lammert F
Gut; 2007 Feb; 56(2):265-70. PubMed ID: 16891356
[TBL] [Abstract][Full Text] [Related]
37. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
van der Woerd WL; van Mil SW; Stapelbroek JM; Klomp LW; van de Graaf SF; Houwen RH
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):541-53. PubMed ID: 20955958
[TBL] [Abstract][Full Text] [Related]
38. NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations.
Davit-Spraul A; Gonzales E; Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):569-73. PubMed ID: 23142591
[TBL] [Abstract][Full Text] [Related]
39. [The MDR3 gene mutation: a rare cause of progressive familial intrahepatic cholestasis (PFIC)].
Maisonnette F; Abita T; Barriere E; Pichon N; Vincensini JF; Descottes B
Ann Chir; 2005 Oct; 130(9):581-3. PubMed ID: 16199000
[TBL] [Abstract][Full Text] [Related]
40. Cholestasis and cholestatic syndromes.
Rutherford AE; Pratt DS
Curr Opin Gastroenterol; 2006 May; 22(3):209-14. PubMed ID: 16550034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
